The QualityStocks Daily Tuesday, October 18th, 2022

Today's Top 3 Investment Newsletters

QualityStocks(COMS) $0.1194 +170.14%

MarketClub Analysis(KPRX) $8.1600 +32.47%

Stocks to Buy Now(NEXCF) $0.7107 +24.68%

The QualityStocks Daily Stock List

Gaucho Group Holdings (VINO)

QualityStocks, MarketClub Analysis, StockWireNews, StockStreetWire, Small Cap Firm, Penny Picks, Fierce Analyst, Damn Good Penny Picks, BeatPennyStocks and AwesomeStocks reported earlier on Gaucho Group Holdings (VINO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gaucho Group Holdings Inc. (NASDAQ: VINO) is a holding firm that is focused on investing in, developing and operating real estate projects in Argentina.

The firm has its headquarters in Miami Beach, Florida and was founded in 1999, on April 5th by Scot L. Mathis. Prior to its name change in March 2019, the firm was known as Algodon Group Inc. It operates in the real estate sector, under the real estate owners and developers’ plus sub-developers’ sub-industry. The firm serves consumers in Argentina as well as in the U.S.

The company identifies and develops investments in the luxury property, hospitality and boutique hotels markets as well in the other lifestyle businesses, like real estate development, tennis, golf and wine production and distribution. It conducts its business in Argentina through Algodon Wine Estates S.R.L, Algodon Properties II S.R.L., the Algodon Recoleta S.R.L., Algodon Global Properties LLC and InvestProperty Group LLC.

The enterprise also operates and owns subdivided property for residential development, a winery and golf resort with hotel, dining and tennis court amenities known as Algodon Wine Estates, which is located in Mendoza and a luxury boutique hotel located in Buenos Aires known as Algodon Mansion. The company distributes wines in Europe via its UK entity and also sells and distributes accessories and high-end luxury fashion products via an e-commerce platform.

The firm recently launched its Amazon Storefront in Buenos Aires, which will enable them to expand their global profile while allowing them to reach more consumers, which will increase the firm’s revenue while also bringing more investors into the firm.

Gaucho Group Holdings (VINO), closed Tuesday's trading session at $0.2599, up 13.8913%, on 2,172,555 volume. The average volume for the last 3 months is 422.906M and the stock's 52-week low/high is $0.1902/$4.93.

COMSovereign Holding (COMS)

Greenbackers, RedChip, Hot Shot Stocks, Trading Markets, QualityStocks, The Street, FreeRealTime, Street Insider, Red Chip, OTCPicks, MarketWatch and Daily Markets reported earlier on COMSovereign Holding (COMS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

COMSovereign Holding Corp. (NASDAQ: COMS) (FRA: 9DA) is a communication technology firm that is focused on designing, developing, marketing and selling technologically advanced telecom solutions.

The firm has its headquarters in Dallas, Texas and was incorporated in 2014, on April 17th by John E. Howelon and Daniel L. Hodges. Prior to its name change in November 2019, the firm was known as Drone Aviation Holding Corp. It serves consumers in the United States.

The company is focused on different capabilities, including hardware, software, antennae, signal modulations and firmware technologies that allow efficient data transmission across the radio-frequency spectrum. It competes internationally based on its customer solutions, product offerings and its technology, as well as the scale of its international distribution and customer base. The company’s product solutions are complemented by an extensive array of services, which include research and development programs, systems design and integration and technical support.

The enterprise’s portfolio includes microwave packet radio equipment, like backhaul telecom radios which transmit broadband voice, data and video. It also provides back-up power solutions and batteries that can be used in marine, aerospace and automotive applications, cellular towers and other radio access network infrastructures. In addition to this, the enterprise provides tethered drones and aerostats for use in reconnaissance, surveillance and intelligence. In addition to this, the enterprise develops silicon photonic devices that are used in computing systems, communication networks and data interconnects.

The company recently announced its latest financial results which show growth in revenues. It is currently focused on its strategic plan to increase production capacity and position the company to play an even bigger role in the modernization of private and public wireless networks.

COMSovereign Holding (COMS), closed Tuesday's trading session at $0.1194, up 170.1357%, on 440,563,290 volume. The average volume for the last 3 months is 215,517 and the stock's 52-week low/high is $0.042/$2.09.


InvestorPlace, MarketClub Analysis, The Online Investor, BUYINS.NET, Wealth Insider Alert, StreetInsider, Schaeffer's, QualityStocks and MarketBeat reported earlier on AYRO Inc. (AYRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AYRO Inc. (NASDAQ: AYRO) (FRA: WR4F) is focused on designing and manufacturing light-duty, emissions-free electric vehicles for government, recreational, closed campus mobility, local delivery, urban and community transport use.

The firm has its headquarters in Round Rock, Texas and was incorporated in 2016, on May 19th. Prior to its name change, the firm was known as AEV Technologies Inc. The firm operates as part of the industrial vehicle manufacturing industry, under the manufacturing sector. It serves consumers in the United States.

The company is focused on designing and delivering compact and electric fleet solutions that can be used in the short-haul and urban markets for last mile delivery and micro-distribution. Its objective is to create sustainable urban electric vehicle solutions for its consumers.

The enterprise is capable of accommodating an extensive range of commercial and consumer requirements. Its vehicles are sustainable, efficient, affordable and safe logistical transportation. It provides a vehicle dubbed the Club Car 411 for cargo services and low-speed logistics for campus; a three-wheeled vehicle dubbed AYRO 311 for personal and professional use; and the AYRO 511. The enterprise serves the government as well as the retail, beverage, food, hotels and resorts, corporate campuses and education industries.

The firm recently appointed a new CEO who has over two decades’ worth of experience in growing technology-driven product development and engineering companies. This move will help drive the firm forward in a developing market, which will in turn usher in the next phase in its development strategy. This may also encourage more investments into the firm.

AYRO Inc. (AYRO), closed Tuesday's trading session at $0.62, up 15.3703%, on 222,472 volume. The average volume for the last 3 months is 300,684 and the stock's 52-week low/high is $0.504/$3.37.

Science 37 (SNCE)

MarketBeat and QualityStocks reported earlier on Science 37 (SNCE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Science 37 Holdings Inc. (NASDAQ: SNCE) is a holding firm focused on developing a technology platform to plan clinical trials and allow specialized networks to execute trials.

The firm has its headquarters in Research Triangle Park, North Carolina and was incorporated in 2014. Prior to its name change in October 2021, the firm was known as Science 37 Inc. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has four companies in its corporate profile and serves consumers in the United States.

The company develops innovative and new treatments which impact patients’ lives by enabling universal access to providers for clinical trials. Its operating system is made up of networks of patient communities, remote coordinators, mobile nurses, telemedicine researchers and connected devices.

The enterprise’s platform provides extensive configuration to support any phase of clinical study and any indication. Its offerings include Study Configuration and Diversity & Inclusion, Technology+, Metasite and Fully DTC. The enterprise also licenses its hosted technology platform to a number of life science institutions. Its consumer base is comprised of biotechnology firms, academic and governmental institutions, contract research organizations, mid-sized and large pharmaceutical firms and medical device companies.

The firm recently released its latest financial results, which show a significant increase in the firm’s revenues. Its CEO noted that the firm was well positioned to deliver on its objectives, which will benefit its shareholders and drive up investments into the firm.

Science 37 (SNCE), closed Tuesday's trading session at $1.33, up 12.7119%, on 300,684 volume. The average volume for the last 3 months is 2.864M and the stock's 52-week low/high is $0.9713/$14.4361.

Wipro Limited (WIT)

MarketBeat, InvestorPlace, Louis Navellier, GorillaTrades, StreetInsider, Daily Trade Alert, The Street, MarketClub Analysis, Trades Of The Day, Market Intelligence Center Alert, Wyatt Investment Research, Kiplinger Today, Zacks, Investor Update, Daily Market Beat, Daily Markets, TheStockAdvisors, Eagle Financial Publications, FNNO Newsletters, Trading Concepts, Investiv, StockHotTips, SmarTrend Newsletters, TopStockAnalysts, The Trading Report, Stockhouse, BUYINS.NET, TradersPro and Uncommon Wisdom reported earlier on Wipro Limited (WIT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wipro Limited (NYSE: WIT) (FRA: WIOA) (VIE: WIOA) (BOM: 507685) (NSE: WIPRO) is an information technology consulting and business process services firm that specializes in IT and computer related technologies.

The firm has its headquarters in Bengaluru, India and was incorporated in 1945, on December 29th. It operates as part of the information technology services industry, under the technology sector. The firm serves consumers around the globe.

The company operates through the IT services, IT products and India state run enterprise services (ISRE) segments. The IT services segment provides IT and IT-enabled services, which include customer-centric design, digital strategy advisory, custom application design, technology and IT consulting, cloud and infrastructure, systems integration, development, re-engineering and maintenance, mobility and analytics, package implementation, research and development, software and hardware design services to enterprises. The IT products segment offers a range of third-party IT products, including networking solutions, enterprise platforms, software and data storage products, enterprise security, contact center infrastructure, video solutions, IT optimization technologies and end-user computing solutions. On the other hand, the ISRE segment provides IT services to departments and entities controlled or owned by the Government of India and/or various Indian State Governments. The company generates more than half of its revenues from North America.

The enterprise recently announced its latest financial results, which show increases in its gross revenue as well as revenues generated from its IT services segment. It remains focused on enhancing the quality of its pipeline and positioning themselves to better serve the changing needs of its consumers. This will bring in additional revenues and investments into the enterprise.

Wipro Limited (WIT), closed Tuesday's trading session at $4.58, off by 1.0799%, on 3,984,374 volume. The average volume for the last 3 months is 146,098 and the stock's 52-week low/high is $4.375/$9.96.

Pioneer Power Solutions (PPSI)

MarketClub Analysis, TradersPro, QualityStocks, StockMarketWatch, Wall Street Resources, TraderPower, MarketBeat,, HotOTC, Investing Futures, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Buzz Stocks, Profitable Trader Authority, StockOnion, Street Insider, The Street, Trades Of The Day, Trading Concepts and PennyStockScholar reported earlier on Pioneer Power Solutions (PPSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pioneer Power Solutions Inc. (NASDAQ: PPSI) is focused on designing, manufacturing and selling electric power systems, new and used power generation equipment, distributed energy resources and mobile electric vehicle charging solutions as well as services.

The firm has its headquarters in Fort Lee, New Jersey and was incorporated in 2008, on September 16th. It operates as part of the electric equipment and parts industry, under the industrials sector. The firm primarily serves consumers in the United States and Canada.

The company operates through the critical power solutions, and the transmission and distribution solutions segments. The critical power solutions segment is engaged in the provision of used and new power generation equipment, and aftermarket field services to ensure uninterrupted and smooth power to operations during times of emergency. On the other hand, the transmission and distribution solutions segment is focused on providing electric power systems, which include E-Bloc and distributed energy resources that enable consumers to efficiently and effectively protect, transfer, control, manage and monitor their electric energy requirements. This segment also offers low voltage transfer switches and switchgears. The company operates as a Provident Pioneer Partners L.P. subsidiary and generates most of its revenue from the U.S. It markets its products to electrical utilities as well as commercial and industrial construction firms.

The enterprise recently secured an $8 million purchase order from an auto-manufacturer for its E-Bloc electrical solution. This move will enable it to extend its global reach while also bringing in additional revenues and growth opportunities into the enterprise.

Pioneer Power Solutions (PPSI), closed Tuesday's trading session at $2.77, up 2.974%, on 146,098 volume. The average volume for the last 3 months is 198,072 and the stock's 52-week low/high is $2.33/$14.4299.

MorphoSys (MOR)

MarketBeat, StockMarketWatch, InvestorPlace, Wealth Insider Alert, Trades Of The Day, The Street, StreetInsider, Daily Trade Alert and BUYINS.NET reported earlier on MorphoSys (MOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MorphoSys AG (NASDAQ: MOR) (FRA: MOR) (ETR: MOR) (SWX: MOR) is a commercial-stage biopharmaceutical firm focused on discovering, developing and commercializing therapeutic antibodies for cancer and autoimmune illnesses.

The firm has its headquarters in Planegg, Germany and was incorporated in July 1992 by Simon E. Moroney and Andreas Pluckthun. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on the United States.

The company is party to a licensing agreement with I-Mab Biopharma, entailing the development and commercialization of felzartamab in Taiwan, China, Macau and Hong Kong. It is also party to a clinical collaboration with Xencor and Incyte Corporation, involving research into the combination of plamotamab, tafasitamab and lenalidomide in patients with relapsed or refractory follicular lymphoma, and relapsed or refractory diffuse large B-cell lymphoma.

The enterprise’s product pipeline is comprised of an antibody for the treatment of B cell malignancies known as Tafasitamab; a small molecule dubbed Pelabresib, which is in phase 2 trials evaluating its effectiveness in treating myelofibrosis; and an antibody directed against CD38 known as Felzartamab, which is in phase I/II trials for treating an autoimmune disease known as anti-PLA2R-positive membranous nephropathy. It also develops an antibody for rheumatoid arthritis known as Otilimab; and an antibody for the treatment of Alzheimer's disease known as Gantenerumab.

The firm, which recently announced its latest financial results, remains focused on advancing its clinical pipeline to help bring new and effective blood cancer medicines to patients. This will benefit patients while also generating significant shareholder value, which will positively influence its growth.

MorphoSys (MOR), closed Tuesday's trading session at $5.56, off by 3.1359%, on 198,072 volume. The average volume for the last 3 months is 3.45M and the stock's 52-week low/high is $4.07/$12.45.

Laser Photonics (LASE)

The Stock Dork, AwesomeStocks, QualityStocks and ProTrader reported earlier on Laser Photonics (LASE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Laser Photonics Corp. (NASDAQ: LASE) is a vertically integrated manufacturing firm that is engaged in the provision of integrated laser-blasting solutions for corrosion control, de-coating, rust removal, laser cleaning, pre- and post-welding and surface conditioning.

The firm has its headquarters in Orlando, Florida and was incorporated in 2019. It operates as part of the specialty industrial machinery industry, under the industrials sector. The firm serves consumers around the globe, with a focus on North Africa, the Americas, the Middle East, Asia and Europe.

The enterprise provides laser cleaning systems, which include air-cooled pulsed laser systems like the CleanTech Handheld LPC-100CTH and CleanTech Handheld LPC-50CTH; a high-power fiber laser for cleaning and surface conditioning dubbed CleanTech Titan Express; a manual handheld laser surface cleaning model known as CleanTech Handheld LPC-200CTH; a laser cleaning tool dubbed CleanTech Handheld LPC-1000CTH; a water-cooled laser system known as CleanTech Handheld LPC-300CTH; an industrial-grade laser parts cleaning, rust removal, and surface conditioning system dubbed CleanTech MegaCenter; a laser cleaning tool known as CleanTech EZ- Rider; and a robotic laser cleaning system dubbed CleanTech Robot. It also offers laser engraving machines; laser cutting machines; laser glass scribing systems; glass cutting lasers; fiber lasers; scanning and cutting heads; and glass wafer dicing products. The enterprise serves the space, shipbuilding, nuclear, defense, automotive and aerospace sectors.

The company is expanding its sales resources, which will help to better meet consumer needs while also bringing in additional revenues and investments into the company. This is in addition to equipping the firm to better handle its growing needs.

Laser Photonics (LASE), closed Tuesday's trading session at $3.55, off by 9.8985%, on 3,450,059 volume. The average volume for the last 3 months is 475,185 and the stock's 52-week low/high is $1.82/$5.50.

Pharvaris (PHVS)

MarketBeat and FreeRealTime reported earlier on Pharvaris (PHVS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pharvaris NV (NASDAQ: PHVS) (FRA: 9EN) is a clinical-stage biopharmaceutical firm that is focused on developing and commercializing treatments for rare ailments.

The firm has its headquarters in Leiden, the Netherlands and was incorporated in 2015, on September 30th by Anne Lesage, Hans Gerardus Christiaan Petrus Schikan, Jochen Knolle, Berndt A. E. Modig, Jens Schneider-Mergener and Luc Dochez. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the Netherlands and Switzerland.

The company is focused on pioneering science for patient choice. It discovers and develops new oral bradykinin B2-receptor antagonists for the treatment of patients with hereditary angioedema and other bradykinin B2-receptor-mediated indications. The company operates in the Netherlands, Switzerland, and the United States.

The enterprise’s product pipeline is comprised of a small molecule bradykinin B2-receptor antagonist dubbed PHA121, which is in phase 2 trials evaluating its effectiveness in treating hereditary angioedema. It also develops a prophylactic extended-release tablet dubbed PHVS719 for hereditary angioedema patients which is in phase 1 trials. This is in addition to developing an on-demand, rapid exposure soft capsule known as PHVS416 which is in phase 2 trials for patients who suffer from hereditary angioedema attacks.

The firm, which recently released its latest financial results, remains focused on advancing its pipeline. The success and approval of its formulations by the FDA will not only benefit patients with hereditary angioedema but also bring in additional investments into the firm, which will, in turn, create value for its shareholders.

Pharvaris (PHVS), closed Tuesday's trading session at $4.79, up 3.2595%, on 476,712 volume. The average volume for the last 3 months is 13.772M and the stock's 52-week low/high is $4.1905/$27.50.

ExxonMobil Corporation (XOM)

Kiplinger Today, InvestorPlace, The Street, StockMarketWatch, The Online Investor, Daily Trade Alert, MarketClub Analysis, StreetAuthority Daily, Schaeffer's, TopStockAnalysts, Market Intelligence Center Alert, Zacks, Money Morning, Trades Of The Day, Investopedia, InvestorGuide, MarketBeat, StreetInsider, Uncommon Wisdom, Investor Guide, Wyatt Investment Research, StocksEarning, Top Pros' Top Picks, Dividend Opportunities, SmarTrend Newsletters, AllPennyStocks, Daily Wealth, Daily Profit, ProfitableTrading, Barchart, The Motley Fool, Investing Daily, The Street Report, TradingAuthority Daily, The Wealth Report, Energy and Capital, Louis Navellier, Money and Markets, TheStockAdvisors, Wealth Insider Alert, Investor Update, Investment U, MarketWatch, Wealth Daily,, Inside Investing Daily, The Growth Stock Wire, Investors Alley, PROFIT CONFIDENTIAL, Daily Markets, Street Insider, WStreet Market Commentary, Trading Markets, Cabot Wealth, GorillaTrades, Insider Wealth Alert, Coattail Investor, Streetwise Reports, CustomerService, Market Intelligence Center, Bourbon and Bayonets, Trading Concepts, TheStockAdvisor, Investiv, CNBC Breaking News, QualityStocks, MarketTamer, Wall Street Daily, Daily Dividends, Stockhouse, All about trends, Forbes, TradingMarkets, InvestorsObserver Team, Average Joe Options, INO Market Report, StreetAlerts, Turn Key Oil, Trader Prep, Trade of the Week and ChartAdvisor reported earlier on ExxonMobil Corporation (XOM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cyclyx International, together with ExxonMobil Corporation (NYSE: XOM) and LyondellBasell Industries (NYSE: LYB), today announced an agreement to advance development of a first-of-its-kind plastic waste sorting and processing facility in the Houston area. According to the update, the new facility addresses a critical missing link in the plastic waste supply chain by connecting community recycling programs to new and more advanced recycling technologies with the potential to take a much wider variety of plastic materials. The Cyclyx Circularity Center will be unique among plastic recovery facilities, leveraging new technologies to analyze and sort plastics based on their composition and best reuse and produce feedstock for both mechanical and advanced recycling. “To help increase the overall U.S. recycling rate and meet growing customer demand for circular products, more investment is needed by governments and industry to collect and sort waste,” said Dave Andrew, vice president of new market development at ExxonMobil. “With this new facility, we are making a substantial investment in plastic waste sorting infrastructure to accelerate our advanced recycling efforts in Baytown and along the Gulf Coast.”

To view the full press release, visit

About Cyclyx International LLC.

Cyclyx is a post-use plastic innovation company working with industry participants to develop innovative recycling solutions for all types of post-use plastics. The company’s mission is to increase the plastic recycling rate from 10% to 90% by using Cyclyx’s expertise in understanding the chemical composition of post-use plastic in collaboration with industry partners to create a new, innovative supply chain. Cyclyx was founded by Agilyx Corporation, a leader in advanced chemical recycling, together with ExxonMobil, one of the largest chemical companies in the world. Cyclyx has been formed to be a consortium-based entity and since its founding there have been a growing number of companies joining its membership. For more information, visit us at

ExxonMobil Corporation (XOM), closed Tuesday's trading session at $100.8, up 0.178891%, on 14,065,435 volume. The average volume for the last 3 months is 75.892M and the stock's 52-week low/high is $57.96/$105.57.

Tesla Inc. (TSLA)

The Street, InvestorPlace, Green Car Stocks, StreetInsider, Schaeffer's, Kiplinger Today, MarketClub Analysis, Investopedia, MarketBeat, Zacks, Daily Trade Alert, Money Morning, Options Elite, The Online Investor, StreetAuthority Daily, Trades Of The Day, Market Intelligence Center Alert, Energy and Capital, All about trends, TopStockAnalysts, Wealth Daily, StocksEarning, InvestorGuide, Uncommon Wisdom, Cabot Wealth, Barchart, CNBC Breaking News, The Motley Fool, Street Insider, MarketWatch, Profit Confidential,, Daily Profit, Money and Markets, ProfitableTrading, Investors Alley, Louis Navellier, Alternative Energy, SmarTrend Newsletters, AllPennyStocks, Wyatt Investment Research, Wealth Insider Alert, StrategicTechInvestor, Investor Guide, Wall Street Daily, Investing Daily, Greenbackers, Investment U, CustomerService, Market Intelligence Center, The Street Report, Stock Up Featured, MarketTamer, Early Bird, FreeRealTime, The Wealth Report, Market Report, Top Pros' Top Picks, Wall Street Elite, Trading Concepts, Daily Wealth, Investiv, The Growth Stock Wire, National Inflation Association, Hit and Run Candle Sticks, InvestorIntel, SureMoney, Investing Futures, Wall Street Profit Search, StockMarketWatch, Short Term Wealth, Jon Markman’s Pivotal Point, GorillaTrades, Insider Wealth Alert, Darwin Investing Network, Market Authority, Streetwise Reports, Trading Tips, Stock Barometer, Total Wealth and equities Canada reported earlier on Tesla Inc. (TSLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

If you own a Tesla Inc. (NASDAQ: TSLA) electric vehicle, you may be wondering why you may not be receiving updates for your vehicle at the same time as other Tesla EV owners. While you may be tempted to surmise that this is due to some inefficiency on the part of the automaker, it turns out that there are perfectly logical reasons why different vehicles receive these (often) monthly updates several days or even weeks apart.

The first consideration that determines when a Tesla vehicle receives an update has to do with the particulars of the vehicle and where that vehicle is located at the time of the update. For example, if you own a Model Y, you may not receive the latest feature update at the same time as owners of the Model S. This is because the company may choose to first send out updates to one model and then send to other models one at a time until all vehicle owners receive the updates. Or a specific update may be intended to address an issue reported in particular models, so other models may receive that update last as a nice-to-have feature.

Similarly, the region where you are located may influence whether your vehicle is first to get an update or whether it’s among those that are updated later. For example, if an improved feature is intended to improve battery performance in regions with more humidity, vehicles in locations that don’t meet this criteria may be updated last while those most likely to benefit will receive the update first.

The second major reason why Tesla sends out updates in a controlled manner is to observe and respond to any issues that may be triggered as those updates are made. If there is a bug in an update that is being rolled out, the technical team quickly addresses that bug before too many Teslas are affected. This bug would be more problematic if all owners of Teslas were negatively affected by a defect brought on by an update to the vehicles’ software and systems.

Once this phased-update release shows that motorists aren’t reporting any problems traceable to that update, the company can then send that particular update to all other Teslas at the same time.

In case you are anxious to receive a particular update, don’t try to force such an update to come through. The company recommends that you keep your vehicle connected to a Wi-Fi network as often as possible because this is the preferred channel through which updates are sent.

Tesla Inc. (TSLA), closed Tuesday's trading session at $220.19, up 0.38295%, on 75,891,905 volume. The average volume for the last 3 months is 435,977 and the stock's 52-week low/high is $204.16/$414.496625.

Warrior Met Coal Inc. (HCC)

MarketBeat, The Online Investor, StreetInsider, Market Report, QualityStocks, Zacks, The Street, Trades Of The Day, Daily Trade Alert, BUYINS.NET, StockMarketWatch, MarketClub Analysis, Schaeffer's, StreetAuthority Daily, AllPennyStocks, Market Intelligence Center Alert, InvestorPlace, Street Insider, CRWEFinance, TopStockAnalysts and SmarTrend Newsletters reported earlier on Warrior Met Coal Inc. (HCC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Thermal coal prices have been declining as supply increases and concerns of shortage are dissipated. The cost of coal used by power plants is, in some areas, dropping to levels recorded prior to Ukraine’s invasion in February. This invasion triggered a sharp increase as buyers expected to incur losses from both nations.

Last week, the Australian benchmark price of 6,000 kcal/kg of coal at the Newcastle Port indicated a $373.75/ton price. This figure, as evaluated by globalCOAL, is a 6.4% decrease from the price recorded on the market’s close the week before. This grade, which is primarily used by utilities in Japan, has declined by more than 17% from its record-setting $452.75/ton price, which was recorded las month.

The cost of coal from Australia with an energy rating of 5,500 kcal/kg has also been declining, with Argus giving it a $161.10 per ton price level last week. This is slightly above the $155.30/ton price that prevailed prior to Ukraine’s invasion. However, it is a significant drop from its record price of $284.20/ton, which was recorded earlier in the year. Argus is a commodity price reporting agency involved in the energy and commodity industry.

The price of 4,200 kcal/kg coal from Indonesia, which is primarily bought by the two largest importers of coal globally — India and China — has also dropped in price. Last week, Indonesian coal was going for $89.75/ton, which represents a 25% decline from its peak of $120.85 recorded after Moscow invaded Ukraine. However, its current price is still higher than its preinvasion tag of $79.53/ton.

In addition, the steep discounts offered on coal from Russia imposed as a result of the heavy bans have also been dropping. This suggests that producers in Russia may have found new buyers given that traditional clients such as South Korea and Japan reduced their imports. Earlier last week, the price of 6,700 kcal/kg of coal from Russia was $190/ton. This represents an almost 20% gain from the $158.50/ton recorded after the invasion. Despite this improvement, this coal grade hasn’t fully recovered to reach its preinvasion tag of $226.3/ton.

Russia may not record exports to Europe though, because the continent plans to enforce its ban on all coal imports from the Kremlin. It is expected that exporters such as Canada, the United States and Colombia will help meet Europe’s demand. Major exporters in Asia may also help meet the demand in Europe.

At the moment, varied trends are being observed despite the fact that wealthier nations are willing to pay more to secure the fuel, to the benefit of extraction companies such as Warrior Met Coal Inc. (NYSE: HCC).

Warrior Met Coal Inc. (HCC), closed Tuesday's trading session at $34.24, up 1.1521%, on 442,689 volume. The average volume for the last 3 months is 50,102 and the stock's 52-week low/high is $20.251/$42.95.

The QualityStocks Company Corner

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Pharma (NASDAQ: SILO) , a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently under development regarding the work of associate professor of clinical Neurobiology Dr. Christine Ann Denny at Columbia University Irving Medical Center. Denny and her team are studying the molecular mechanisms underlying learning and memory, including diseases such as Alzheimer’s disease. According to the announcement, Denny’s pioneering research is evaluating whether ketamine and novel inventions associated with the substance have potential to improve memory retrieval as well as halt or even reverse the process of memory loss and cognitive aging related to Alzheimer's. “The first steps of our research with Columbia have been positive, and we’re happy to extend this research and option pact to continue the progress of SPC-14 as an Alzheimer's therapeutic and SPC-15 for stress-induced anxiety disorders," said Silo Pharma CEO Eric Weisblum in the press release. To view the full press release, visit . Last month, a hemp dispensary located in Florida began to sell psychedelic mushrooms. The dispensary, Chillum, was founded by Carlos Hermida in 2018. Hermida is pushing legal boundaries because psilocybin is still illegal inthe county due to its Schedule I classification under the Controlled Substances Act. Drugs under this classification have no legal medical purpose and a high potential for abuse. Other drugs under this schedule include LSD and heroin. Hermida is basing his sales on a legal loophole that allows him to sell Amanita muscaria mushrooms that do not contain psilocybin. This makes them legal under federal law. Additionally, this red-and-white mushroom is legal in all states in the country except for Louisiana. To sell the shrooms, Hermida doesn’t call them magic mushrooms, because this term is associated with psilocybin, the primary psychedelic compound found in traditional hallucinogenic mushrooms. He argues that only when drugs are a problem are they banned, noting that muscaria’s low uptake had protected it from regulation.

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.


Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Tuesday's trading session at $5.08, up 1.6%, on 50,102 volume. The average volume for the last 3 months is 46,014 and the stock's 52-week low/high is $4.46/$12.445.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP) , a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential clients, media and investors with an opportunity to see Knightscope’s game-changing security robots up close and personal. The stop in Dallas is at the Commemorative Air Force location from 10 a.m. to 3 p.m. CT. Knightscope is committed to share its offerings through creative marketing events, and the roadshow is an ideal example of this. So far, the event has landed in 64 different locations across 23 states and the District of Columbia. The robots tour the U.S. in what the company describes as a space-age, NASA-like pod, allowing attendees to experience all the technology that is enabling these autonomous security robots to help make sites safer today from Hawaii to Texas to North Carolina. At each stop, Knightscope experts guide visitors through direct interaction with ASRs and provide an opportunity to see the Knightscope Security Operations Center user interface in action. To view the full press release, visit

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Tuesday's trading session at $2.65, up 1.9231%, on 46,087 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $12.445/$.

Recent News

Odyssey Group International Inc. (OTC: ODYY)

The QualityStocks Daily Newsletter would like to spotlight Odyssey Group International Inc. (OTC: ODYY).

Odyssey acquired IP and all rights to PRV-002, its lead drug candidate for the treatment of concussions, on March 1, 2021, and has since made notable progress in a strategic move to have the drug approved by the FDA

Since the acquisition, the company has completed IND enabling studies and all cohorts for Phase I SAD and MAD clinical trials for its lead drug candidate

In pre-clinical studies PRV-002 has demonstrated equivalent, if not superior neuroprotective effects compared to related neurosteroids, offering proof of reduced behavioral pathology associated with brain injury symptoms, easily crossing the blood-brain barrier to rapidly eliminate swelling, oxidative stress, and inflammation in the brain

Odyssey’s management is pleased with the progress so far, as the drug advances in its clinical and regulatory pathway and, subsequently, tapping into the concussion treatment market projected to be valued at $8.9 billion by 2027

On March 1, 2021, Odyssey Health (OTC: ODYY) , a medical company with a focus on unique, life-saving medical products that offer clinical advantages to unmet clinical needs, acquired intellectual property (“IP”) and all rights to PRV-002, its lead drug candidate for the treatment of concussions ( ). For a condition affecting millions worldwide, Odyssey recognized a significant unmet medical need and set off to offer a viable solution to the problem.

Odyssey Group International Inc. (OTC: ODYY) is a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care.

The company’s portfolio of product technologies is diverse, featuring four unique medical products in development. Odyssey’s goal is to deliver superior products with enhanced clinical utility and market potential, thereby yielding a high rate of return for its shareholders and partners. It is guided by a senior management team with significant experience relating to refining technologies, building commercial systems and forging strategic partnerships.

Product Portfolio


Odyssey has two pharmaceutical products in development:

  • PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. Importantly, the first-in-class novel neurosteroid demonstrated no drug-related toxicity in these trials.
    • PRV-002 is currently being evaluated in a phase I clinical trial for the treatment of concussion, with phase II trials planned for launch in Fall 2022. Odyssey has also highlighted the potential of PRV-002 for additional indications such as Alzheimer’s disease, Parkinson’s disease, ALS and chromic traumatic encephalopathy (CTE).
  • PRV-001 is a novel compound intended to treat Niemann-Pick disease, a rare neurodegenerative-lysosomal storage disorder that affects an estimated 1 in 150,000 individuals in the U.S., demonstrating a 5x higher incidence in Middle Eastern populations.
    • Odyssey expects to receive Orphan Drug designation from the FDA for PRV-001, which would accelerate its pathway to FDA approval and provide seven years of market exclusivity.

Medical Devices

Odyssey is also developing two medical device candidates:

  • CardioMap® is intended to provide early, non-invasive testing for heart disease. The system offers a number of potential advantages over traditional EKGs, including requiring less training to operate, offering heightened sensitivity and coming in a small and portable form factor. CardioMap is being developed for a 510(k) regulatory pathway, which requires a study to demonstrate equivalence to legacy EKG offerings.
    • When approved, CardioMap is expected to be the only device in its class that has a predictive value, illustrating ‘grey’ areas where deterioration has begun but not yet led to pathology. Odyssey expects this feature to provide a powerful incentive for doctors to use the CardioMap device in end markets such as hospitals, doctors’ offices, rehabilitation centers and sports medicine practices.
  • Save-A-Life (SAL) is a patented, single-action, instantaneous, handheld, mechanical anti-choking device that creates a vacuum chamber in the mouth to dislodge throat obstructions in a matter of seconds, all without harm to the victim. The device is currently in development, with a proof of concept established.
    • Odyssey believes that, once FDA-approved, its anti-choking device will quickly become the “accepted” standard and leader in the treatment of choking incidents globally. Its low-cost manufacturing and convenient portable design give SAL a competitive edge over competing devices utilizing cumbersome masks.

Market Opportunities

Odyssey’s varied development pipeline positions it to address a number of sizable market opportunities with significant unmet medical need. Concussions alone currently account for medical costs of roughly $10-15 billion annually in the U.S., despite the lack of a currently approved FDA drug treatment. This need is particularly apparent in the military and sports industry, where the likelihood of athlete head-injury recurrence is estimated at 75%.

It is for this reason that, in March 2021, Odyssey announced the formation of a sports advisory board featuring well-known athletes supporting the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Members of Odyssey’s sports advisory board include NFL Hall of Famers Kurt Warner & Brett Favre and two-time Olympic gold medalist Abby Wambach.

With its CardioMap platform, Odyssey is targeting the global cardiac monitoring market, which was valued at $28 billion in 2021 by Insight Partners and forecast to reach $43 billion by 2028.

Save-A-Life targets a similarly underserved market. Choking is the fourth-leading cause of death in children, and approximately 5,000 choking deaths occur each year in the U.S. While 95% of these deaths result from in-home incidents, current choking rescue devices fail to address in-home applications.

Management Team

Joseph Michael Redmond is the President, CEO and Chairman of Odyssey. He has over 30 years of commercial experience in medical device companies, previously serving as CEO of Parallax Health Sciences Inc., V.P. of Business Development for DxTech Inc. and V.P. of Sales and Marketing for Bioject Medical Technologies Inc. While at Bioject, Mr. Redmond helped raise over $15 million in capital, entered into several licensing and distribution deals with major biotech and pharmaceutical companies and grew the market cap of the company from under $10 million to over $400 million. He started his career at Abbott Labs and holds a B.A. from Denison University.

Christine M. Farrell is the company’s CFO and Secretary. Prior to joining Odyssey, Ms. Farrell was Vice President of Finance for Bioject Medical Technologies Inc. She also held accounting and financial management positions with Spar-Tek Industries, a manufacturer of high quality and cutting-edge technology for the plywood industry, and Action Machinery, a seller of new and used robotic machine tools and equipment. Ms. Farrell holds a B.A. in Accounting from the University of Washington and an M.B.A. from Willamette University.

Dr. Jacob W. Vanlandingham is Odyssey’s Head of Drug Development. Dr. Vanlandingham holds a Ph.D. in neuroscience with a molecular biology focus. He is a member of the Society for Neuroscience, American Society for Nutritional Sciences, National Neurotrauma Society, Faculty for Undergraduate Research in Neuroscience and the International Association of Medical Science Educators.

Odyssey Group International Inc. (OTC: ODYY), closed Tuesday's trading session at $0.4, up 3.8961%, on 612,223 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.11/$0.64.

Recent News

Cub Crafters Inc.

The QualityStocks Daily Newsletter would like to spotlight Cub Crafters Inc.

  • The market for light and ultralight aircraft is expected to grow at a CAGR of 5.9 percent between 2022 and 2030, achieving sales of $11.9 billion
  • Backcountry aircraft developer CubCrafters is awaiting SEC qualification for a public offering, to take advantage of rising interest in this sector of the aviation industry
  • The Yakima, Wash.-based company has been building airplanes modeled on the classic Piper PA-18 Super Cub for over 40 years and has advanced to designing its own aircraft based on the same legacy

Yakima, Wash.-based aircraft manufacturer CubCrafters has started a takeoff roll toward blue skies that offer the potential promise of corporate development through public investment. The popular light aircraft designer and builder has enjoyed over 40 years of producing best-in-class backcountry aircraft that began with the legacy of the classic Piper PA-18 Super Cub and progressed to include its own new designs in the Experimental, LSA, and Part 23 Certified aircraft categories.

Cub Crafters Inc. (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (STC) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (FAA) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility.

The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (FAA) type certified in December 2004. The Top Cub was also granted type certificates (TC) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (LSA) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S.

CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments.

CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft.


The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying.

The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard.

The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018.

CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming.

In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub.

Market Overview

According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel.

CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market.

Management Team

Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees.

Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees.

Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University.

Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide.

Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design.

Recent News


REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

Last week, President Joseph Biden announced that individuals convicted of simple cannabis possession under federal law would be pardoned of their convictions . This proclamation thrust the country’s marijuana policy into the limelight, with the president also urging governors to pardon those convicted of the same under state law. At the moment, marijuana is classified as a Schedule I substance under the Controlled Substances Act. All substances classified under this schedule are thought to have a high potential for abuse and no currently accepted medical use. Other substances under this schedule include LSD and heroin. This classification is difficult to understand, especially if one considers the fact that marijuana’s categorization is even harsher than that of methamphetamine and fentanyl, which are currently driving the country’s overdose epidemic. During his announcement, Biden stated that classification made no sense then directed that the health secretary and attorney general conduct a review on whether marijuana should be classified as a less-serious substance. Voters in five other states — South Dakota, North Dakota, Missouri, Maryland and Arkansas — are set to vote on measures to allow the recreational use of marijuana. Additionally, four separate ballot referendums are expected in the coming years. If all these jurisdictions pass cannabis reform policies, there will be a bigger market for entities such as REZYFi Inc. , which is bridging the financing gaps created by the reluctance of mainstream banks to work with marijuana businesses.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

Inflation Reduction Act flips the script of green economy; until recently economic growth took primacy over energy transition; now they go hand in hand

Credit Suisse cites clean energy as safe, smart, government-backed bet for conservative investors; moreover, it is expected to perform regardless of the macro environment

As a company empowering homeowners and businesses to achieve Net-Zero, GeoSolar well positioned to capitalize on this growing green momentum

The days of assuming that we need economic growth before we can start tackling climate change are gone. Once an afterthought dependent on the upward trajectory of the broader economy, now climate change is gearing up to drive growth. Against this backdrop, it appears that the times for companies like GeoSolar Technologies (“GST”), a Colorado-based climate technology company, may have never been better.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


QSAM Biosciences Inc. (OTCQB: QSAM)

The QualityStocks Daily Newsletter would like to spotlight QSAM Biosciences Inc. (OTCQB: QSAM).

Two studies recently conducted by Cedars-Sinai Cancer scientists have discovered new information that may improve the understanding of why some patients don’t respond to treatment and what drives ovarian cancer development. Epithelial ovarian cancer is the most common ovarian cancer type, developing in the epithelial tissue. It is estimated that roughly 85% of ovarian tumors are epithelial. The first study affords researchers a better understanding into how ovarian tumors develop resistance to treatment. Resistance usually develops in nearly 80% of high-grade serous tumors of patients with ovarian cancer. The co-first author for this study, Michelle Jones, stated that whole genome sequencing had led to the discovery that most high-grade serous ovarian tumors could survive chemotherapy from the early stages . This finding goes against popular belief that ovarian tumors evolved after exposure to chemotherapy, which enabled them to survive and adapt throughout the treatment period. While these particular researchers focused on ovarian cancer, teams at different companies, such as QSAM Biosciences Inc. (OTCQB: QSAM) , are studying other forms of cancer with a view to bringing to market more effective remedies that also have a better safety profile free from many of the dreaded side effects that conventional cancer treatments are notorious for triggering.

QSAM Biosciences Inc. (OTCQB: QSAM) is a clinical stage biotechnology company focused on bringing to market targeted therapeutic radiopharmaceuticals. The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients.

QSAM Biosciences was founded in 2020 by Executive Chairman Dr. C. Richard Piazza and CEO Douglas Baum. It is headquartered in Austin, Texas.


CycloSam®, QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. By leveraging a patented, low specific activity form of Samarium-153 (resulting in far less undesirable europium impurity) and what management believes to be a superior chelating agent in DOTMP, CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the bone tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters are currently being tested in an FDA-cleared clinical trial.

CycloSam® has been shown in laboratory testing to cause significantly less (30x less) buildup of long-lived radionuclidic impurities than prior FDA-approved drugs, which management believes will enable the ability to safely administer therapeutic doses via higher and multiple-dose regimens and effectively expand its potential clinical utility to therapeutic uses in areas of high unmet medical needs.

The indications for CycloSam® currently being evaluated by QSAM Biosciences include:

  • Metastatic Bone Cancers – On April 28, 2022, QSAM Biosciences announced that the first patient had commenced treatment in its clinical trial evaluating CycloSam in patients with metastatic bone cancer. As noted in the release, the study is a Phase 1 open-label, dose-escalation trial to evaluate the safety, tolerability, dosimetry, and preliminary efficacy of CycloSam®.
  • Pediatric Osteosarcoma/Ewing’s Sarcoma – On February 2, 2022, the company announced that the U.S. FDA has granted Rare Pediatric Disease Designation to CycloSam for the treatment of osteosarcoma. Combined with a previously granted orphan drug designation for osteosarcoma received in 2021, this milestone “may allow QSAM to potentially bring CycloSam® to market more rapidly through additional incentives and eligibilities,” according to CEO Douglas Baum.
  • Bone Marrow Ablation – In a 2020 single patient Investigational New Drug (IND) study, an investigator concluded that high-dose CycloSam® can be administered safely to ablate bone marrow in advance of a stem cell transplant with no apparent renal toxicity and no unexpected adverse events attributable to the drug.

QSAM Biosciences’ preclinical and clinical development pipeline is supported by a strong IP portfolio. The company has secured 14 patents across three distinct patent families spanning the U.S., Japan, Canada and the European Union.

Market Outlook

Through its ongoing development of CycloSam®, QSAM Biosciences is targeting multiple large and underserved market opportunities. According to the American Cancer Society, roughly 400,000 new cases of malignant bone metastasis are diagnosed annually in the U.S. alone. Additionally, QSAM will pursue indications for osteosarcoma and Ewing’s sarcoma that are the most common primary malignancies of bone tissues in children.

Despite this pressing need, the current standard of care for bone cancer is aggressive and suboptimal, leading to marginal success with significant side effects and poor long-term survival prognosis. As a result, QSAM Biosciences estimates a sizable market opportunity for its development pipeline.

  • Bone Metastasis has an estimated total addressable market of $20 billion in the U.S. based on total new cases and comparable drug pricing.
  • Osteosarcoma/Ewing’s Sarcoma have a total addressable market of roughly $125 million in the U.S. based on approximately 1,000 new cases in 2021.
  • The total addressable market for Bone Marrow Ablation is projected at $1 billion, with an estimated 32,000 procedures completed annually.

The company anticipates that the ability to administer CycloSam® for higher and multiple-dose regimens may expand its clinical utility for therapeutic uses in additional areas of high unmet medical needs.

Management Team

QSAM Biosciences is led by an experienced management team and board with an extensive record of FDA approvals, big pharma partnerships and M&A transactions.

Dr. C. Richard Piazza is the Executive Chairman of QSAM Biosciences. Since 2017, he has also served as President and CEO of IGL Pharma Inc., the licensor of CycloSam®, and as a consultant to IsoTherapeutics Group LLC, the inventors of the technology. Dr. Piazza also currently serves on the board of directors of NovaScan LLC, a privately held cancer detection and diagnostics company. He has more than 48 years of health care experience in both medical devices and pharmaceutical/biotech and has led several technology companies to market success, including numerous FDA approvals in both sectors. Dr. Piazza obtained a BS in Economics and a BS in Speech Pathology from the State University of New York and an MA & PhD in Economics from the University of Buffalo and Leeds University.

Douglas R. Baum is the company’s CEO and Director. He brings to QSAM Biosciences over 30 years of experience in the bioscience and biotech industries, including development, FDA/EMA approval and commercialization of multiple drugs and medical devices. Mr. Baum has overseen 15 product approvals through the FDA and EMA and raised over $85 million in capital to fund breakthrough technologies. From 2017 to 2020, he consulted with multiple medical schools and biotech and pharmaceutical companies, and, from 2012 to 2017, he served as President, Chief Executive Officer and Director of Xeris Pharmaceuticals Inc. Mr. Baum holds a Master of Science in Technology Commercialization and a BBA in International Business and Marketing from the University of Texas.

Adam King is the CFO of QSAM Biosciences. He is also the Founder and CEO of King Consulting Group, where he provides a range of financial and reporting services for clients. Before founding King Consulting Group in January 2021, Mr. King was the CFO for Netsertive, a venture-backed digital marketing company. From 2016 to 2018, he was the Office Managing Audit Director for BDO’s Greenville, South Carolina, office, in addition to serving as Audit Director in Raleigh, North Carolina, and Boston, Massachusetts. While at BDO, Mr. King worked with various clients, from tech and life science start-ups to billion-dollar publicly traded companies. He holds a Bachelor of Science in Accounting from Elon University and is a CPA in Raleigh, North Carolina.

QSAM Biosciences Inc. (OTCQB: QSAM), closed Tuesday's trading session at $5.8, off by 1.6949%, on 200 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.50/$14.796.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru, and Quebec

Company released positive results from 21 diamond drill holes at Iska Iska Bolivia project revealing silver, tin, zinc, lead

New borehole geophysical data expanding Santa Barbara high-grade feeder zone with potential strike length of at least 2 kilometers

Eloro has option to acquire 99 percent interest in the Iska Iska property, owns 82 percent interest in La Victoria Gold/Silver project in Peru

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) , a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru, and Quebec, recently released positive results from its fully financed drill program at its Iska Iska project in Bolivia ( ). Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) , an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at its Iska Iska silver-tin polymetallic project and is reporting on two diamond drill holes. According to the announcement, drill hole DSB-36 collared 400m southeast of the Santa Barbara adit, tested the extension of the core of the high-grade feeder zone at Santa Barbara while hole DSB-34 tested the potential southwest limits of the high-grade feeder zone. Eloro noted that so far 118 drill holes have been completed at Iska Iska, including four holes that are currently in progress, and the company intends to continue to carry out strategic sectional drilling across the Iska Iska caldera valley, with four additional holes planned to complete its first-pass definition drill program. “Results from hole DSB-36 continue to confirm that the high-grade feeder zone extends much further south-southeast across the valley of the Iska Iska caldera as interpreted from our geophysical surveys,” said Eloro Resources CEO Tom Larsen in the press release. “This new hole has extended the strike length a further 400m to the south-southeast where it remains open along strike. We are continuing to aggressively drill this important target which has the potential to outline a significant open pittable resource. To view the full press release, visit .

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Tuesday's trading session at $2.43021, off by 4.3224%, on 22,007 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.09/$4.46.

Recent News

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

Correlate’s strategic investments in clean electrification solutions and commercial solar infrastructure have earned the company a growing customer base, and an opportunity pipeline of over $100 million in commercial projects

The company recognizes the rise in EV and solar adoption and looks to tap into this growth to increase its revenues, brand equity, and market reach

Todd Michaels, the company’s Founder, President, and CEO, acknowledges that “It has never been a better time for [our] business”

With solar and EV adoption set to grow significantly this year, and with the company’s recent acquisition and planned acquisitions, Correlate is set to meet or exceed its revenue targets

Correlate Infrastructure Partners (OTCQB: CIPI) , a driver of highly cost-effective solutions for energy use optimization, is looking to capitalize on the growing rate of renewable energy adoption in a move that Correlate management is confident will guarantee the company’s growth. Correlate offers a complete suite of proprietary clean energy assessment solutions for the commercial real estate industry, developing and financing renewable energy projects designed to make these investment properties more efficient, and in a way that is remarkably affordable.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.


Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Tuesday's trading session at $1.68, off by 0.591716%, on 537 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.32/$3.25.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

The Renewable Natural Gas (“RNG”) market is forecast to grow to an annual market size of $72.13 billion by 2027

EverGen purchased a 66% stake in Albert-based agri operation, GrowTEC for a gross consideration of $2.1 million

EverGen are in the process of building out the required infrastructure needed to inject the company’s RNG production into the local electric grid

Elsewhere, the company also announced that Sean Hennessey would take over the vacant CFO position, substituting the company’s existing interim CFO, Natasha Monk

On October 9th, Chevron announced their intention to produce and market dairy biomethane as a renewable natural gas (“RNG”) transportation fuel in California. Meanwhile and across the country, Michigan regulators began to review permit applications for a new renewable natural gas plant situated on a landfill site as a way to tackle the land mass’ toxic air contaminant emissions. With growth within the renewable natural gas sector proceeding at a breakneck pace, it comes as no surprise that a recent study has forecast the renewable natural gas market size to swell to an annual value of $72.13 billion by 2028, equivalent to a CAGR of 44.0% over the next six years. British-Columbia based natural gas operator, EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) in particular has been on the very forefront of the sector’s development within Canada and the world.

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Tuesday's trading session at $1.58, off by 3.6585%, on 800 volume. The average volume for the last 3 months is 800 and the stock's 52-week low/high is $1.365/$4.21.

Recent News

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F)

The QualityStocks Daily Newsletter would like to spotlight Hillcrest Energy Technologies Ltd. (OTCQB: HLRTF).

The IEA sees EV sales hitting a record in 2022 after doubling in 2021 from 2020, while noting the lack of charging infrastructure as an obstacle for adoption

Hillcrest Energy has developed a new class of inverters that convert DC output from batteries into AC input used by motors in EVs

Hillcrest filed a patent application for new tech that eliminates the need for EVs to require and onboard charger, allowing for faster, anywhere charging

During an interview last week with CNBC’s Jim Cramer, Mercedes-Benz CEO Ola Kallenius said he is seeing the market for luxury vehicles progressively turning towards electric vehicles. The Daimler unit has a corporate goal to have an EV version of every model it makes by 2025 and to be all-electric where possible by the end of the decade. The global transition to phase out internal combustion engines is wonderful for Mother Earth, but it is accompanied by a litany of challenges, including a charging conundrum related to strain on an aging and already overworked electricity grid. The good news is that thanks to companies like Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) , new technology is becoming available as a solution applicable to EVs and other emerging green energy products. Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) , a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, has signed an agreement with Hercules Electric Mobility to bring customizable electric mobility products to market. Leaders from the two companies — HLRTF CEO Don Currie and Hercules Electric Mobility CEO James Breyer — discussed the partnership on a recent Proactive interview with host Steve Darling, noting that the partnership is aimed at integrating the latest technologies into new, innovative products and accelerating the path to market. To view the full interview, visit . To view the full press release, visit

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) is a clean technology company based in Vancouver, British Columbia, engaged in developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems.

From concept to commercialization, Hillcrest invests in the development of energy solutions that power a more sustainable and electrified future. Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (EV), motors and generators.

The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements.

As momentum to electrify and decarbonize energy systems accelerates, Hillcrest believes the power inverter is increasingly emerging as a key component. While system cohorts such as battery packs, PV panels and electric motors are often in the spotlight, the inverter holds the key to unlocking efficiency and performance improvements.

Hillcrest power inverter technology is:

  • REVOLUTIONARY: high-efficiency inverter technology has the potential to revolutionize how motors respond and how efficiency is gained.
  • AGILE: able to deliver and deploy high-efficiency inverter solutions purpose-designed to meet specific customer needs.
  • INNOVATIVE: technology-forward, clean-energy experts who are focused on advancing and optimizing efficient alternative energy use across all electric vehicle and charging platforms.
  • A MARKET LEADER: a next-generation technology provider to the automotive industry’s top suppliers and manufacturers.

Technology & Applications

Hillcrest’s first application for its inverter technology – a 250 kW|800V Hillcrest SiC high efficiency traction inverter – is focused on the growing EV market. Hillcrest technology eliminates traditional design trade-offs faced across the power industry – deploying higher switching frequencies has historically meant a greater increase in losses, lower system efficiency and higher heat. Through a combination of hardware and software expertise, Hillcrest enables power applications to leverage higher switching frequencies AND

  • Realize improved power system performance and reliability
  • Operate at higher power levels without compromising efficiency

The expected benefits of Hillcrest’s traction inverter have been confirmed via testing and shared in a technical white paper, published in April 2022, that confirmed the following results:

  • Significant efficiency gains – 99%-plus inverter efficiency
  • Increased power density targeting 50kW/L+
  • Significantly increased motor efficiency
  • Lower stress on mechanical and electrical parts, enhancing reliability
  • Improved thermal management

Hillcrest has also filed a patent for an enhanced powertrain solution that offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefit of the enhanced powertrain solution is the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless, and bidirectional charging across current and future power levels. Hillcrest sees this as a true EV charging game changer.

The company’s technology applies to nearly every clean energy industry segment:

  • Wind power – an inverter is deployed at a wind turbine generator to convert the AC output, with at least one additional inverter used to deliver the power to the grid/battery.
  • Solar power – an inverter is used to convert the DC output from the photovoltaic panels into the AC power that flows to the grid/battery/home.
  • Energy storage – an inverter is deployed to convert the DC output from the storage system or batteries to the AC power that flows to the grid/home/EV.
  • EV fast chargers – an inverter converts the AC input from the grid/storage system to the DC output needed to charge an EV’s battery.

Market Outlook

According to an April 2022 market analysis by Vantage Market Research (VMR), the global power inverter market is expected to reach a value of $95 billion by 2028, driven by increasing demand for EVs, energy generating wind turbines and solar-powered photovoltaic systems. That jump is forecast from an estimated $70.5 billion market value in 2021 and represents a compound annual growth rate of more than 5%.

According to the VMR report, many governments in countries around the world are supporting alternative options for efficient and nonpolluting energy generation. This has boosted demand for wind energy and solar energy systems. Hillcrest is aiming to capture a share of this future market growth across nearly every segment of the clean energy industry.

Management Team

Don Currie is the founding CEO of Hillcrest Energy Technologies. He has led the company’s successful transition from fossil fuels into clean energy technologies. Earlier in his career, he held various senior level positions, including director, officer and vice president of corporate communications with Enhanced Oil Resources Inc., an oil and gas exploration and production company based in Houston. Prior to that, he worked in other private and public ventures spanning the mining, gaming and technology sectors.

Jamie L. Hogue is the COO of Hillcrest. She brings more than two decades of progressive policy leadership, economic analysis and organizational development experience to Hillcrest. She builds collaborative processes and solutions that drive growing organizations toward a more resilient future. She previously served as the director of operations for Arizona State University’s Ten Across initiative – a compelling observatory positioned on the front lines of economic, social and climate change. She earned a master’s degree in public administration and a bachelor’s degree in economics from Arizona State University.

Ari Berger is Chief Technology Officer at Hillcrest. He brings over a decade of commercial experience with a track record of deploying new electrification technologies and go-to-market strategies. In 2015, he founded NIG Systems Ltd. in Israel, which specializes in custom high performance control systems design. Prior to this, he previously worked for Bental Industries, a leading motor manufacturer. He holds a master’s degree in system control engineering from the Technion – Israel Institute of Technology.

Raj Clair is CFO at Hillcrest. She is a CPA who began her career at Deloitte and has served in advanced finance positions in the energy and resources sector. She has been responsible for reporting, audits and internal controls, as well as working on budgeting and forecasting. She has worked with various publicly listed companies, including SEC registrants, and has both Canadian and U.S. experience. She holds a bachelor’s degree in accounting from Simon Fraser University.

Hillcrest Energy Technologies Ltd. (NASDAQ: HLRTF), closed Tuesday's trading session at $0.09949, off by 1.5925%, on 17,337 volume. The average volume for the last 3 months is 17,337 and the stock's 52-week low/high is $0.072/$0.1789.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton (NASDAQ: CPTN) , a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on Tuesday, Nov. 8, 2022. In addition, Cepton will hold a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 888-999-6281 and visiting for the live webcast. A replay will be available approximately two hours after the live call and until Nov. 22, 2022, and can be accessed by dialing 844-512-2921 and entering passcode 3684645. An archived webcast of the conference call will be accessible on Cepton’s Investor Relations page. To view the full press release, visit

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Tuesday's trading session at $2.25, off by 3.4335%, on 292,206 volume. The average volume for the last 3 months is 291,692 and the stock's 52-week low/high is $1.01/$80.16.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.